Xanthine Oxidase Is Involved in Free Radical Production in Type 1 Diabetes
Tóm tắt
The aim of this work was to study the mechanism of free radical formation in type 1 diabetes and its possible prevention. We have found oxidation of blood glutathione and an increase in plasma lipoperoxide levels in both human type 1 diabetes and experimental diabetes. Peroxide production by mitochondria does not increase in diabetes. On the contrary, the activity of xanthine oxidase, a superoxide-generating enzyme, increases in liver and plasma of diabetic animals. The increase in plasma xanthine oxidase activity may be explained by the increase in the hepatic release of this enzyme, which is not due to nonspecific membrane damage: release of other hepatic enzymes, such as the amino transferases, does not increase in diabetes. Superoxide formation by aortic rings of rabbits increases significantly in diabetes. This is completely inhibited by allopurinol, an inhibitor of xanthine oxidase. Heparin, which releases xanthine oxidase from the vessel wall, also decreases superoxide formation by aortic rings of diabetic animals. Treatment with allopurinol decreases oxidative stress in type 1 diabetic patients: hemoglobin glycation, glutathione oxidation, and the increase in lipid peroxidation are prevented. These results may have clinical significance in the prevention of late-onset vascular complications of diabetes.
Từ khóa
Tài liệu tham khảo
Baynes J: Role of oxidative stress in development of complications in diabetes. Diabetes 40:405–412,1991
Wolff SP: Diabetes mellitus and free radicals: free radicals, transition metals and oxidative stress in the aetiology of diabetes mellitus and complications. Br Med Bull 49:642–652,1993
Hunt JV, Dean RT, Wolff SP: Hydroxyl radical production and autoxidative glycosylation: glucose autoxidation as the cause of protein damage in the experimental glycation model of diabetes mellitus and ageing. Biochem J 256:205–212,1988
Jain SK, Mc Vie R, Jaramillo JJ, Chen Y: Hyperketonemia (acetoacetate) increases the oxidizability of LDL + VLDL in type-I diabetic patients. Free Rad Biol Med 24:175–181,1998
Jain SK, Kannan K, Lim G: Ketosis (acetoacetate) can generate oxygen radicals and cause increased lipid peroxidation and growth inhibition in human endothelial cells. Free Rad Biol Med 25:1083–1088,1998
Jain SK, McVie R, Jackson R, Levine SN, Lim G: Effect of hyperketonemia on plasma lipid peroxidation levels in diabetic patients. Diabetes Care 22:1171–1175,1999
Viña J, Hems R, Krebs HA: Maintenance of glutathione content in isolated hepatocytes. Biochem J 170:627–630,1978
Asensi M, Sastre J, Pallardó FV, Estrela J, Viña J: Determination of oxidized glutathione in blood: high-performance liquid chromatography. Methods Enzymol 234:367–371,1994
Asensi M, Sastre J, Pallardó FV, García de la Asunción J, Estrela JM, Viña J: A high-performance liquid chromatography method for measurement of oxidized glutathione in biological samples. Anal Biochem 217:323–328,1994
Bergmeyer HU: Methods of Enzymatic Analysis, 2nd ed. New York, Academic Press,1974
Beckman JS, Parks DA, Pearson JD, Marshall PA, Freeman BA: A sensitive fluorometric assay for measuring xanthine dehydrogenase and oxidase in tissues. Free Rad Biol Med 6:607–615,1989
Richard MJ, Guiraud P, Meo J, Favier A: High-performance liquid chromatographic separation of malondialdehyde-thiobarbituric acid adduct in biological materials (plasma and human cells) using a commercially available reagent. J Chromatogr 577:9–18,1992
White CR, Darley-Ushmar V, Berrington WR, McAdams M, Gore JZ, Thompson JA, Parks DS, Tarpey MM, Freeman BA: Circulating plasma xanthine oxidase contributes to vascular dysfunction in hypercholesterolemic rabbits. Proc Natl Acad Sci U S A 93:8745–8749,1996
Rickwood DW, Wilson MT, Darley-Usmar VM: Isolation and characteristics of intact mitochondria. In Mitochondria: A Practical Approach. Darley-Ulmar VM, Wilson MT, Rickwood D, Eds. Oxford, Washington, IRL Press,1987, p.4–6
Viña JR, Sáez GT, Viña J: The physiological functions of glutathione. In CRC Handbook of Free Radicals and Antioxidants in Biomedicine. Miguel J, Quintanilha AT, Weber H, Eds. Boca Raton, FL, CRC Press,1989, p.121–132
Miguel J, Economos AC, Fleming J, Johnson JE Jr: Mitochondrial role in cell aging. Exp Gerontol 15:575–591,1980
Sastre J, Pallardó FV, Plá R, Pellín A, Juan G, O’Connor E, Estrela JM, Miguel J, Viña J: Aging of the liver: age-associated mitochondrial damage in intact hepatocytes. Hepatology 24:1199–1205,1996
García de la Asunción J, Millán A, Plá R, Bruseghini L, Esteras A, Pallardó FV, Sastre J, Viña J: Mitochondrial glutathione oxidation correlates with age-associated oxidative damage to mitochondrial DNA. FASEB J 10:333–338,1996
Linnane A, Marzuki S, Ozawa T, Tanaka M: Mitochondrial DNA mutations as an important contributor to aging and degenerative diseases. Lancet i:642–645,1989
García de la Asunción J, Del Olmo ML, Sastre J, Millán A, Pellín A, Pallardó FV, Viña J: AZT treatment induces molecular and ultrastructural oxidative damage to muscle mitochondria. Prevention by antioxidant vitamins. J Clin Invest 101:1–6,1998
Heunks LM, Vina J, van Herwaarden CL, Folgering HT, Gimeno A, Dekhuijzen PN: Xanthine oxidase is involved in exercise-induced oxidative stress in chronic obstructive pulmonary disease. Am J Physiol 277:R1697–R1704,1999
Adachi T, Fukushima T, Usami Y, Hirano K: Binding of human xanthine oxidase to sulphated glycosaminoglycans on the endothelial-cell surface. Biochem J 289:523–527,1993
McLennan S, Heffernan S, Wright L, Rae C, Fisher E, Yue DK, Turtle JR: Changes in hepatic glutathione metabolism in diabetes. Diabetes 40:344–348,1991
Lubec B, Hermon M, Hoeger H, Lubec G: Aromatic hydroxylation in animal models of diabetes mellitus. FASEB J 12:1581–1587,1998
Traverso N, Menini S, Odetti P, Pronzato MA, Cottalasso D, Marinari U: Lipoperoxidation in hepatic subcellular compartments of diabetic rats. Free Rad Biol Med 26:538–547,1999
Cosentino F, Hishikawa K, Katusic ZS, Luscher TF: High glucose increases nitric oxide synthase expression and superoxide anion generation in human aortic endothelial cells. Circulation 96:25–28,1997
Parks DA, Granger DN: Xanthine oxidase: biochemistry, distribution and physiology. Acta Physiol Scand Suppl 548:87–99,1986
Yokoyama Y, Beckman JS, Beckman TK, Wheat JK, Cash TG, Freeman BA, Parks DA: Circulating xanthine oxidase: potential mediator of ischemic injury. Am J Physiol 258:G564–G570,1990
Cardillo C, Kilcoyne CM, Cannon RO 3rd, Quyyumi AA, Panza JA: Xanthine oxidase inhibition with oxypurinol improves endothelial vasodilator function in hypercholesterolemic but not in hypertensive patients. Hypertension 30:57–63,1997